Detalhe da pesquisa
1.
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.
Cell
; 184(8): 2033-2052.e21, 2021 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33765443
2.
The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid ß Peptide Fibrils.
Mol Imaging
; 17: 1536012118796297, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30213230
3.
Zfp281 and Zfp148 control CD4+ T cell thymic development and TH2 functions.
Sci Immunol
; 8(89): eadi9066, 2023 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37948511
4.
In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration.
Nucl Med Biol
; 112-113: 20-30, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35763877
5.
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
Sci Adv
; 8(7): eabj7002, 2022 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35179953
6.
Synthesis, characterization, and monkey PET studies of [¹8F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435.
Synapse
; 65(2): 125-35, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20524178
7.
The synthesis and preclinical evaluation in rhesus monkey of [¹8F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers.
Synapse
; 65(4): 261-70, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20687108
8.
In Vitro Evaluation of [3H]CPPC as a Tool Radioligand for CSF-1R.
ACS Chem Neurosci
; 12(6): 998-1006, 2021 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33667059
9.
Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
Mol Imaging Biol
; 22(4): 832-841, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31728839
10.
Esophageal extracellular matrix hydrogel mitigates metaplastic change in a dog model of Barrett's esophagus.
Sci Adv
; 6(27): eaba4526, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32656339
11.
Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
Synapse
; 63(12): 1122-32, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19670309
12.
Reversal of warfarin-coagulopathy: How to improve plasma transfusion practice in a community hospital setting?
Asian J Transfus Sci
; 13(2): 100-104, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31896915
13.
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype.
Tissue Eng Part A
; 25(5-6): 487-498, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30259795
14.
Structural Basis for Achieving GSK-3ß Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery.
J Med Chem
; 62(21): 9600-9617, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31535859
15.
Diagnostic and therapeutic challenges.
Retina
; 33(3): 661-5, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23386115
16.
Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.
Nucl Med Biol
; 34(8): 1009-17, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17998106
17.
Extracardiac manifestations of atrial myxomas.
J Saudi Heart Assoc
; 29(1): 37-43, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28127217
18.
Advancing Drug Discovery and Development Using Molecular Imaging (ADDMI): an Interest Group of the World Molecular Imaging Society and an Inaugural Session on Positron Emission Tomography (PET).
Mol Imaging Biol
; 19(3): 348-356, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28417265
19.
Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization.
Mol Imaging Biol
; 7(4): 314-23, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16080024
20.
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist.
Pharmacol Res Perspect
; 3(6): e00198, 2015 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27022470